Claim 50% Off TipRanks Premium and Invest with Confidence
- Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential
LTR Pharma Limited ( (AU:LTP) ) has provided an announcement.
LTR Pharma Limited announced a change in the interest of its director, Maja McGuire, involving the acquisition of 1,000,000 unlisted options under the company’s Employee Incentive Plan. This move, approved at the 2025 Annual General Meeting, reflects the company’s commitment to aligning its leadership’s interests with its strategic goals, potentially impacting its market positioning and stakeholder confidence.
More about LTR Pharma Limited
Average Trading Volume: 848,857
Technical Sentiment Signal: Sell
Current Market Cap: A$88.08M
For detailed information about LTP stock, go to TipRanks’ Stock Analysis page.